ClinicalTrials.Veeva

Menu

Hypotension Prediction Index for Blood Pressure Management (HPI)

NeuroTherapia, Inc. logo

NeuroTherapia, Inc.

Status

Completed

Conditions

Intraoperative Hypotension

Treatments

Device: Control
Device: Acumen HPI-enabled EV1000 screen

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Design: Single-center randomized comparison of invasive arterial pressure monitoring vs. arterial pressure monitoring combined with Acumen Hypotension Prediction Index (HPI) software guidance on intraoperative hypotension duration and severity.

Aim: To determine whether use of Acumen HPI software guidance to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension.

Primary hypothesis: Our primary hypothesis is that adding Acumen HPI software guidance to the information provided by the invasive arterial pressure monitoring during moderate- to high-risk noncardiac surgery reduces time-weighted average (TWA) intraoperative hypotension below a threshold of 65 mmHg.

Full description

STUDY RATIONALE Even when clinicians try to prevent intraoperative hypotension, they often fail because it is difficult to predict which patients will become hypotensive, much less when. A risk score for predicting minute-by-minute intraoperative hypotension is not currently available. Yet it seems likely that ability to identify when a patient is likely to become hypotensive, and the pathophysiology of the event, will improve hemodynamic management and perhaps patient outcome. Acumen HPI appears to be a reliable predictor of intraoperative hypotension, and should thus help clinicians anticipate and avoid hypotension. Furthermore, the secondary guidance provided by the Acumen HPI may help clinicians optimally manage fluids and thus prevent future episodes in the same patient.

AIMS To determine whether use of Acumen HPI software to guide intraoperative hemodynamic management in the non-cardiac surgery reduces the duration and severity of hypotension.

PRIMARY HYPOTHESIS Our primary hypothesis is that use of the Acumen HPI software guidance reduces TWA intraoperative hypotension below a threshold of 65 mmHg.

Specifically, we will compare the amount of intraoperative hypotension below mean-arterial pressure (MAP) threshold of 65 mmHg, in patients randomized to invasive arterial pressure monitoring vs. invasive arterial pressure monitoring with Acumen Hypotension Prediction Index software. In both cases, clinicians will strive to keep MAP above 65 mmHg to the extent practical.

Enrollment

214 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Age ≥45 years
  • ASA Physical Status 3 or 4
  • Moderate- or high-risk surgery (for example, orthopedic, spine, urology, and general surgery)
  • Planned invasive blood pressure monitoring
  • General anesthesia
  • Surgery duration expected to last >2 hours
  • Planned overnight hospitalization

Exclusion criteria

  • Contraindication to the invasive blood pressure monitoring
  • Pregnancy
  • Emergency surgery
  • Known clinically important intracardiac shunts
  • Known aortic stenosis with valve area ≤ 1.5 cm2
  • Known moderate to severe aortic regurgitation
  • Known moderate to severe mitral regurgitation
  • Known moderate to severe mitral stenosis
  • Patient or surgical procedure type known as an SVV limitation16 (e.g. tidal volume <8mL/kg of theoretical ideal weight, spontaneous ventilation, persistent cardiac arrhythmia, known atrial fibrillation, open chest surgery, Heart Rate/Respiratory Rate (HR/RR) ratio <3.6)
  • Current persistent atrial fibrillation
  • Congestive heart failure with ejection fraction <35%
  • Neurosurgery
  • Emergent or cardiovascular surgical procedure
  • Patient who is confirmed to be pregnant
  • Refusal of patient or authorized representative to sign consent

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

214 participants in 2 patient groups, including a placebo group

Arterial line - Control
Placebo Comparator group
Description:
Arterial line waveform and pressure
Treatment:
Device: Control
Acumen HPI-enabled EV1000 screen
Experimental group
Description:
Arterial line waveform and pressure + HPI alert from EV1000 monitor
Treatment:
Device: Acumen HPI-enabled EV1000 screen

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems